10X GENOMICS INC's ticker is TXG and the CUSIP is 88025U109. A total of 306 filers reported holding 10X GENOMICS INC in Q4 2020. The put-call ratio across all filers is 0.38 and the average weighting 1.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $1,905,312,000 | +359.1% | 66,900 | +1126.2% | 0.03% | +480.0% |
| Q1 2022 | $415,038,000 | -48.9% | 5,456 | 0.0% | 0.01% | -37.5% |
| Q4 2021 | $812,726,000 | +11.0% | 5,456 | +8.5% | 0.01% | 0.0% |
| Q3 2021 | $732,267,000 | -25.7% | 5,030 | 0.0% | 0.01% | -20.0% |
| Q2 2021 | $984,975,000 | +8.2% | 5,030 | 0.0% | 0.01% | 0.0% |
| Q1 2021 | $910,430,000 | +27.8% | 5,030 | 0.0% | 0.01% | +25.0% |
| Q4 2020 | $712,248,000 | – | 5,030 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Venrock Management VI, LLC | 962,309 | $174,178,000 | 96.89% |
| Foresite Capital Management II, LLC | 2,253,528 | $407,889,000 | 93.76% |
| Foresite Capital Management I, LLC | 1,000,000 | $181,000,000 | 91.29% |
| 12 West Capital Management LP | 1,922,000 | $347,882,000 | 16.58% |
| FINANCIAL CONSULATE, INC | 158,758 | $28,735,000 | 11.65% |
| Meritech Capital Associates V L.L.C. | 2,123,356 | $384,327,000 | 9.48% |
| Andar Capital Management HK Ltd | 48,000 | $8,688,000 | 9.16% |
| JS Capital Management LLC | 517,256 | $93,623,000 | 4.84% |
| Ground Swell Capital, LLC | 3,713 | $672,000 | 2.17% |
| Renaissance Capital LLC | 79,518 | $14,393,000 | 2.13% |